The α2-adrenoceptor antagonists idazoxan and RX811059 induced reciprocal forepaw treading, a component of the 5-HT-behavioural syndrome in rats. This response is independent of 'non-α2-adrenoceptor idazoxan binding sites' (NAIBS) at which RX811059 is inactive. Idazoxan pre-treatment, in rats, enhanced forepaw treading, head weaving and tremor induced by the 5-HT agonist 5-methoxy-N,N dimethyltryptamine (5-MeODMT), increased head twitches (but decreased hindlimb abduction) induced by the 5-HT releaser p- chloroamphetamine (pCA), but did not clearly alter head twitches induced by the 5-HT precursor L-5-hydroxytryptophan in mice. The α1-antagonist prazosin did not alter behaviour induced by either 5-MeODMT or pCA in rats. The α 2-agonist, guanoxabenz, did not alter 5-MeODMT-induced behaviour in rats. St587, an α1-agonist, selectively potentiated tremor induced by 5-MeODMT, but no other behaviour. A possible mechanism for these interactions could be through enhanced, α2-adrenoceptor-mediated, 5-HT release in specific brain areas. Other possibilities, e.g. direct action at subtypes of 5-HT receptors and the importance of these NA-5-HT interactions in the treatment of resistant depression, are discussed.
Get full access to this article
View all access options for this article.
References
1.
Baraban J.M., Aghajanian G.K. (1980) Suppression of firing activity of 5-HT neurones in the dorsal raphe by α-adrenoreceptor antagonistsNeuropharmacology19: 355-363
2.
Baraban J.M., Aghajanian G.K. (1981) Noradrenergic innervation of serotonergic neurons in the dorsal raphe: demonstration by electron microscopic autoradiography . Brain Res204: 1-11
3.
Benkirane S., Arbilla S., Langer S.Z. (1986) Newly synthesized noradrenaline mediates the α 2-adrenoceptor inhibition of [3H ] -5-hydroxytryptamine release induced by β-phenylethylamine in rat hippocampal slicesEur J Pharmacol131: 189-198
4.
Berridge T.L., Gadie B., Roach A.G., Tulloch I.F. (1983) α2-Adrenoceptor agonists induce mydriasis in the rat by an action within the central nervous systemBr J Pharmacol78: 507-515
5.
Brown C.M., MacKinnon A.C., McGrath J.C., Spedding M., Kilpatrick A.T. (1990) α2-Adrenoceptor subtypes and imidazoline-like binding sites in the rat brainBr J Pharmacol99: 803-809
Crossley D.I. (1984) The effects of idazoxan, an α2-adrenoreceptor antagonist in depression—a preliminary investigation. IUPHAR 9th International Congress of Pharmacology, London, 1724p
8.
Dickinson S.L., Curzon G. (1983) Roles of dopamine and 5-hydroxytryptamine in stereotyped and non-stereotyped behaviourNeuropharmacology22: 805-812
9.
Dickinson S.L., Andrews C.D., Curzon G. (1984) The effects of lesions produced by 5,7-dihydroxytryptamine on 5-hydroxytryptamine-mediated behaviour induced by amphetamine in large doses in the ratNeuropharmacology23: 423-429
10.
Dickinson S.L., Gadie B., Tulloch IF (1990) Specific α2-adrenoceptor antagonists induce behavioural activation in the ratJ. Psychopharmacol4: 90-99
11.
Doxey J.C., Roach A.G., Stillings M.R., Strachan D.A., Virdee N.K., Welbourn AP (1984) Potent and selective α2adrenoceptor antagonists in a series of 2-substituted analogues of idazoxanBr J Pharmacol81: 181P
12.
Doxey J.C., Lane A.C., Roach A.G., Smith C F C, Walter D.S. (1985) Selective α2-adrenoceptor agonists and antagonists In Szabadi E, Bradshaw C M, Nahorski S R (eds), Pharmacology of adrenoceptors. Macmillan Press, pp. 13-22
13.
Ennis C. (1983a) Different α-adrenoceptors modulate the release of 5-hydroxytryptamine and noradrenaline in rat cortexBr J Pharmacol79: 279-283
14.
Ennis C. (1983b) The release of 5-hydroxytryptamine in the occipital and frontal cortex is modulated by different subtypes of α-arlrenoceptorJ Pharm Pharmacol35: 750-751
15.
Fozard J.R., McDermott I. (1985) The cardiovascular response to 8-hydroxy-2-(di-n-propylamino)-tetralin (8-OH-DPAT) in the ratBr J Pharmacol84: 69P
16.
Frankhuyzen A.L., Mulder A.H. (1980) Noradrenaline inhibits depolarisation-induced [3H ] -serotonin release from slices of rat hippocampusEur J Pharmacol63: 179-182
17.
Galzin A.M., Moret C., Langer S.Z. (1984) Evidence that exogenous but not endogenous norepinephrine activates the presynaptic α2-adrenoceptors on serotonergic nerve endings in the rat hypothalamusJ Pharmacol Exp Ther228: 725-732
18.
Garratt J.C., Crespi F., Mason R., Marsden C.A. (1991) Effects of idazoxan on dorsal raphe 5-hydroxytryptamine neuronal dysfunctionEur J Pharmacol193: 87-93.
19.
Garratt J.C., Marsden C.A. (1990) Effect of chronic idazoxan on dorsal raphe nucleus 5-HT neuronal firingEur J Pharmacol183: 1911-1912
20.
Gothert M., Huth H., Schlicker E. (1981) Characterisation of the receptor subtype involved in α-adrenoceptor-mediated modulation of serotonin release from brain cortex slicesNaunyn-Schmiedeberg's Arch Pharmacol317: 199-203
21.
Grahame-Smith D.G. (1971) Studies in vivo on the relationship between brain tryptophan, brain 5-HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L-tryptophanJ Neurochem18: 1053-1066
22.
Green A.R., Heal D.J., Johnson P., Laurence BE, Nimgaonkar V.L. (1983) Antidepressant treatments: effects in rodents on dose-response curves of 5-hydroxytryptamine and dopamine-mediated behaviour and 5-HT2 receptor number in frontal cortexBr J Pharmacol80: 377-385
23.
Handley S.L., Brown J. (1982) Effects on the 5-hydroxytryptamine-induced head-twitch of drugs with selective actions on α1- and α2-adrenoceptorsNeuropharmacology21: 507-510
24.
Heal D.J., Philpot J., O'Shaughnessy K.M., Davies C.L. (1986) The influence of central noradrenergic function on 5-HT2-mediated head-twitch responses in mice: possible implications for the actions of antidepressant drugsPsychopharmacology89: 414-420
25.
Jacobs B.L. (1976) An animal behaviour model for studying central serotonergic synapsesLife Sci19: 777-786
26.
Jacobs B.L., Klemfuss H. (1975) Brain stem and spinal cord mediation of a serotonergic behavioural syndromeBrain Res100: 450-457
27.
Limberger N., Bonanno G., Spath L., Starke K. (1986) Autoreceptors and α2-adrenoceptors at the serotonergic axons of rabbit brain cortexNaunyn-Schmiedeberg's Arch Pharmacol332: 324-331
28.
Marsden C.A., Martin K.F. (1986) Involvement of 5-HT1Aand α 2-receptors in the decreased 5-hydroxytryptamine release and metabolism in rat suprachiasmatic nucleus after intravenous 8-hydroxy-2-(n-dipropylamino) tetralinBr J Pharmacol89: 277-286
29.
Maura G., Gemignani A., Raiteri M. (1982) Noradrenaline inhibits central serotonin release through α2-adrenoceptors located on serotonergic nerve terminalsNaunyn-Schmiedeberg's Arch Pharmacol320: 272-274
30.
Michel M.C., Brodde O-E., Schnepel B., Behrendt J., Tschada R., Motulsky H.J., Insel P.A. (1989) [3H ] -Idazoxan and some other α 2-adrenergic drugs also bind with high affinity to a nonadrenergic siteMol Pharmacol35: 324-330
31.
Montgomery S.A. (1988) Alpha-2-antagonists and depressive illnessJ Psychopharmacol2: Suppl.
32.
Nimgaonkar V.L., Green A.R., Cowen P.J., Heal D.L., Grahame-Smith D.G., Deakin J F W (1983) Studies on the mechanisms by which clenbuterol, a β-adrenoceptor agonist, enhances 5-HT-mediated behaviour and increases metabolism of 5-HT in the brain of the ratNeuropharmacology22: 739-749
33.
Ogren S.O., Fuxe K., Agnati L.F., Celani M.F. (1983) Effects of antidepressant drugs on cerebral serotonin receptor mechanismsActa Pharmacol Toxicol56: Suppl 1, 105-127
34.
Ortmann R., Waldmeier P.C., Radeke E., Felner A., Delini-Stula A. (1980) The effects of 5-HT uptake and MAO-inhibitors on L-5-HTP-induced excitation in ratsNaunyn-Schmiedeberg's Arch Pharmacol311: 185-192
35.
Ortmann R., Martin S., Radeke E., Delini-Stula A. (1981) Interaction of β-adrenoceptor agonists with the serotonergic system in rat brainA behavioural study using the L-5-HTP syndromeNaunyn-Schmiedeberg's Arch Pharmacol316: 225-230
36.
Osman O.T., Rudorfer M.V., Potter W.Z. (1989) Idazoxan: A selective α2-antagonist and effective sustained antidepressant in two bipolar depressed patientsArch Gen Psychiatr46: 958-959
37.
Pettibone D.J., Pfleuger A.B., Totaro J.A. (1985) Comparison of the effects of recently developed α 2-adrenergic antagonists with yohimbine and rauwolscine on monoamine synthesis in rat brainBiochem Pharmacol34: 1093-1097
38.
Pichler L., Kobinger W. (1985) α2-Adrenoceptor blocking properties of the α1-selective agonist 2-(2-chloro-5-trifluoromethylphenylimino) imidazoline (St587)Arzneim Forsch Drug Res35: 201-205
39.
Reinhard J.F., Galloway M.P., Roth R.H. (1983) Noradrenergic modulation of serotonin synthesis and metabolism II Stimulation by 3-isobutyl-1-methylxanthineJ Pharmacol Exp Ther226: 764-769
40.
Sloviter R.S., Drust E.G., Connor J.D. (1978) Specificity of a rat behavioural model for serotonin receptor activationJ Pharmacol Exp Ther206: 339-347
41.
Stolz J.F., Marsden C.A., Middlemiss D.N. (1983) Effect of chronic antidepressant treatment and subsequent withdrawal on [3H ]-5-hydroxytryptamine and [ 3H]-spiperone binding in rat frontal cortex and serotonin receptor mediated behaviourPsychopharmacology80: 150-155
42.
Timmermans P B M W M, Mathy M-J., Wilffert R., Kalkman H.O., Smit G., Dijkstra D., Horn A.S., Van Zwieten P.A. (1984) α1/α2-adrenoceptor agonist selectivity of mono-and dihydroxy-2-N,N-di-n-propylaminotetralinsEur J Pharmacol97: 55-65
43.
Tricklebank M.D., Forler C., Fozard J.R. (1985a) The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-propylamino) tetralin in the ratEur J Pharmacol106: 271-282
44.
Tricklebank M.D., Forler C., Middlemiss D.N., Fozard J.R. (1985b) Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the ratEur J Pharmacol117: 15-24
45.
Tricklebank M.D., Neill J., Kidd E.J., Fozard JR (1987) Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT 1A receptorEur J Pharmacol133: 47-56
46.
Trulson M.E., Jacobs B.L. (1976) Behavioural evidence for the rapid release of CNS serotonin by pCA and fenfluramineEur J Pharmacol36: 149-154
47.
Trulson M.E., Crisp T. (1984) Role of norepinephrine in regulating the activity of serotonin-containing dorsal raphe neuronsLife Sci35: 511-515
48.
Vetulani J., Bednarczyk B., Reichenberg K., Rokosz A. (1980) Head twitches induced by LSD and quipazine: similarities and differencesNeuropharmacology19: 155-158
49.
Waldmeier PC (1981) Stimulation of central serotonin turnover by β-adrenoceptor agonistsNaunyn-Schmiedeberg's Arch Pharmacol317: 115-119
50.
Wichmann T., Limberger N., Starke K. (1989) Release and modulation of release of serotonin in rabbit superior colliculusNeuroscience32: 141-151
